Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Overweight × licogliflozin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 1 Overweight 1 Obesity 1 Insulin Resistance 1 Hyperandrogenism 1

Interventions

licogliflozin 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Naltrexone 1 Exercise 1 Exenatide 1 Diet, Plant-Based 1 Counseling 1 Bupropion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03152591 2021-01-05

PCOS

Novartis

Phase 2 Completed

29 enrolled 24 charts

Insulin Resistance, Obesity, Polycystic Ovary Syndrome, Hyperandrogenism, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon ⚡